Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.676 USD | -3.40% | +12.49% | +32.41% |
May. 20 | Sector Update: Health Care Stocks Ease Monday Afternoon | MT |
May. 20 | Atara Biotherapeutics Files Biologics License Application for Tabelecleucel with FDA; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.41% | 84.27M | |
+11.06% | 115B | |
+12.79% | 106B | |
-4.52% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.29% | 17.56B | |
-39.36% | 17.32B | |
+7.51% | 14.03B | |
+32.89% | 12.13B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- JPMorgan Adjusts Price Target on Atara Biotherapeutics to $22 From $27, Reiterates Overweight Rating